The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

Drugs like Ozempic, Wegovy and Zepbound have transformed how we treat obesity, but more effective treatments could be down ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...

Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts.

US price cuts, Medicare expansion, and new oral GLP-1 approvals reshape the competitive outlook for weight-loss drugs.

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...

Earlier this week, the FDA approved Eli Lilly and Company’s LLY rival Novo Nordisk’s NVO oral version of the obesity drug ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

With the oral version of the slimming drug, the Danish company aims to regain ground, win over millions of patients and strengthen its position against competitors such as Eli Lilly.

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, ...

As a registered dietitian in Eastern Oregon, I work with patients living with obesity. The Food and Drug Administration has ...